##gff-version 3
##sequence-region Q15125 1 230
Q15125	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:25944712;Dbxref=PMID:25944712	
Q15125	UniProtKB	Chain	2	230	.	.	.	ID=PRO_0000174342;Note=3-beta-hydroxysteroid-Delta(8)%2CDelta(7)-isomerase	
Q15125	UniProtKB	Transmembrane	29	49	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q15125	UniProtKB	Transmembrane	66	86	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q15125	UniProtKB	Transmembrane	121	141	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q15125	UniProtKB	Transmembrane	185	205	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q15125	UniProtKB	Domain	61	204	.	.	.	Note=EXPERA;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU01087	
Q15125	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylthreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:25944712;Dbxref=PMID:25944712	
Q15125	UniProtKB	Natural variant	18	18	.	.	.	ID=VAR_074633;Note=In MEND%3B patients have mildly increased concentrations of plasma 8(9)-cholestenol and 8-dehydrocholesterol%3B probable hypomorphic mutation. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12503101;Dbxref=dbSNP:rs104894795,PMID:12503101	
Q15125	UniProtKB	Natural variant	47	47	.	.	.	ID=VAR_074634;Note=In MEND%3B patients have increased concentrations of plasma 8(9)-cholestenol%2C 8-dehydrocholesterol and 7-dehydrocholesterol%3B probable hypomorphic mutation. W->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20949533;Dbxref=dbSNP:rs587783599,PMID:20949533	
Q15125	UniProtKB	Natural variant	47	47	.	.	.	ID=VAR_074635;Note=In MEND%3B patients have increased concentrations of plasma 8-dehydrocholesterol and 8(9)-cholestenol%3B probable hypomorphic mutation. W->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24459067;Dbxref=dbSNP:rs878854359,PMID:24459067	
Q15125	UniProtKB	Natural variant	75	75	.	.	.	ID=VAR_074636;Note=In MEND%3B patients have increased plasma levels of 8(9)-cholestenol%3B probable hypomorphic mutation. I->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24700572;Dbxref=dbSNP:rs797045153,PMID:24700572	
Q15125	UniProtKB	Natural variant	80	80	.	.	.	ID=VAR_012105;Note=In CDPX2. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10391219;Dbxref=dbSNP:rs104894800,PMID:10391219	
Q15125	UniProtKB	Natural variant	103	103	.	.	.	ID=VAR_074637;Note=In CDPX2. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18176751;Dbxref=PMID:18176751	
Q15125	UniProtKB	Natural variant	110	110	.	.	.	ID=VAR_012106;Note=In CDPX2. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10391218;Dbxref=PMID:10391218	
Q15125	UniProtKB	Natural variant	147	147	.	.	.	ID=VAR_012107;Note=In CDPX2. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11493318;Dbxref=PMID:11493318	
Q15125	UniProtKB	Natural variant	147	147	.	.	.	ID=VAR_012108;Note=In CDPX2. R->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10391219,ECO:0000269|PubMed:10942423,ECO:0000269|PubMed:25814754;Dbxref=dbSNP:rs28935174,PMID:10391219,PMID:10942423,PMID:25814754	
Q15125	UniProtKB	Mutagenesis	68	68	.	.	.	Note=Reduces catalytic activity to less than 35%25 of wild-type. W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9894009;Dbxref=PMID:9894009	
Q15125	UniProtKB	Mutagenesis	75	75	.	.	.	Note=Reduces catalytic activity to less than 35%25 of wild-type. I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9894009;Dbxref=PMID:9894009	
Q15125	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Reduces catalytic activity to less than 10%25 of wild-type. H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9894009;Dbxref=PMID:9894009	
Q15125	UniProtKB	Mutagenesis	80	80	.	.	.	Note=Reduces catalytic activity to less than 10%25 of wild-type. E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9894009;Dbxref=PMID:9894009	
Q15125	UniProtKB	Mutagenesis	111	111	.	.	.	Note=Reduces catalytic activity to less than 2%25 of wild-type. Y->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12760743;Dbxref=PMID:12760743	
Q15125	UniProtKB	Mutagenesis	121	121	.	.	.	Note=Reduces catalytic activity to less than 35%25 of wild-type. M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12760743;Dbxref=PMID:12760743	
Q15125	UniProtKB	Mutagenesis	121	121	.	.	.	Note=No effect on catalytic activity. M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12760743;Dbxref=PMID:12760743	
Q15125	UniProtKB	Mutagenesis	122	122	.	.	.	Note=Reduces catalytic activity to less than 10%25 of wild-type. E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9894009;Dbxref=PMID:9894009	
Q15125	UniProtKB	Mutagenesis	125	125	.	.	.	Note=Reduces catalytic activity to less than 10%25 of wild-type. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9894009;Dbxref=PMID:9894009	
Q15125	UniProtKB	Mutagenesis	188	188	.	.	.	Note=Reduces catalytic activity to less than 35%25 of wild-type. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9894009;Dbxref=PMID:9894009	
Q15125	UniProtKB	Mutagenesis	189	189	.	.	.	Note=Reduces catalytic activity to less than 35%25 of wild-type. F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12760743;Dbxref=PMID:12760743	
Q15125	UniProtKB	Mutagenesis	189	189	.	.	.	Note=No effect on catalytic activity. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12760743;Dbxref=PMID:12760743	
Q15125	UniProtKB	Mutagenesis	193	193	.	.	.	Note=Reduces catalytic activity to less than 10%25 of wild-type. N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9894009;Dbxref=PMID:9894009	
Q15125	UniProtKB	Mutagenesis	196	196	.	.	.	Note=Reduces catalytic activity to less than 10%25 of wild-type. W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9894009;Dbxref=PMID:9894009	
Q15125	UniProtKB	Sequence conflict	187	188	.	.	.	Note=FY->IF;Ontology_term=ECO:0000305;evidence=ECO:0000305	
